受强制性开放获取政策约束的文章 - Glen Clack了解详情
无法在其他位置公开访问的文章：2 篇
Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma
L Khoja, P Shenjere, C Hodgson, J Hodgetts, G Clack, A Hughes, ...
Melanoma research 24 (1), 40-46, 2014
强制性开放获取政策： Cancer Research UK
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer–results of two parallel first-in-human phase I studies
A Omlin, RJ Jones, R Van Der Noll, T Satoh, M Niwakawa, SA Smith, ...
Investigational new drugs 33, 679-690, 2015
强制性开放获取政策： Cancer Research UK, Prostate Cancer UK, Swiss Cancer League
可在其他位置公开访问的文章：16 篇
Evaluation and prognostic significance of circulating tumor cells in patients with non–small-cell lung cancer
MG Krebs, R Sloane, L Priest, L Lancashire, JM Hou, A Greystoke, ...
Journal of clinical oncology 29 (12), 1556-1563, 2011
强制性开放获取政策： Cancer Research UK
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and-independent approaches
MG Krebs, JM Hou, R Sloane, L Lancashire, L Priest, D Nonaka, TH Ward, ...
Journal of thoracic oncology 7 (2), 306-315, 2012
强制性开放获取政策： Cancer Research UK
Circulating tumor cells as a window on metastasis biology in lung cancer
JM Hou, M Krebs, T Ward, R Sloane, L Priest, A Hughes, G Clack, ...
The American journal of pathology 178 (3), 989-996, 2011
强制性开放获取政策： Cancer Research UK
Clinical development of new drug–radiotherapy combinations
RA Sharma, R Plummer, JK Stock, TA Greenhalgh, O Ataman, S Kelly, ...
Nature reviews Clinical oncology 13 (10), 627-642, 2016
强制性开放获取政策： Cancer Research UK, UK Engineering and Physical Sciences Research Council …
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
L Khoja, A Backen, R Sloane, L Menasce, D Ryder, M Krebs, R Board, ...
British journal of cancer 106 (3), 508-516, 2012
强制性开放获取政策： Cancer Research UK
Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma
L Khoja, P Lorigan, C Zhou, M Lancashire, J Booth, J Cummings, ...
Journal of Investigative Dermatology 133 (6), 1582-1590, 2013
强制性开放获取政策： Cancer Research UK
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single …
MT Dillon, Z Boylan, D Smith, J Guevara, K Mohammed, C Peckitt, ...
Clinical and Translational Radiation Oncology 12, 16-20, 2018
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a phase I study
TA Yap, MG Krebs, S Postel-Vinay, A El-Khouiery, JC Soria, J Lopez, ...
Clinical Cancer Research 27 (19), 5213-5224, 2021
强制性开放获取政策： National Institute for Health Research, UK
Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system
KL Aung, E Donald, G Ellison, S Bujac, L Fletcher, M Cantarini, G Brady, ...
The Journal of Molecular Diagnostics 16 (3), 343-349, 2014
强制性开放获取政策： Cancer Research UK
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours
KL Aung, RE Board, G Ellison, E Donald, T Ward, G Clack, M Ranson, ...
The HUGO journal 4, 11-21, 2010
强制性开放获取政策： Cancer Research UK
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
RC Coombes, S Howell, SR Lord, L Kenny, J Mansi, Z Mitri, C Palmieri, ...
Nature communications 14 (1), 4444, 2023
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: a short communication
A Greystoke, G Harris, M Jenkins, D Goonetilleke, D Moore, M Lancashire, ...
Journal of pharmaceutical and biomedical analysis 84, 184-188, 2013
强制性开放获取政策： Cancer Research UK
Lipid profiles within the SABRE trial of anastrozole with and without risedronate
C Van Poznak, A Makris, G Clack, DH Barlow, R Eastell
Breast cancer research and treatment 134, 1141-1147, 2012
强制性开放获取政策： US National Institutes of Health
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single …
M Dillon, S Ellis, L Grove, L McLellan, G Clack, S Smith, J Laude, Z Viney, ...
ASCO, 2016
强制性开放获取政策： Cancer Research UK
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
MA Pruis, MG Krebs, R Plummer, F De Vos, E Angevin, H Prenen, ...
The oncologist 28 (12), e1248-e1258, 2023
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Clinical and Translational Radiation Oncology
MT Dillon, Z Boylan, D Smith, J Guevara, K Mohammed, C Peckitt, ...
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
出版信息和资助信息由计算机程序自动确定